Your cart is currently empty!
Brand Orslim Item Form Tablets Quantity 30 Delivery Time 2-3 Business Shipping Free Offer 1000 Imported From USA
Orlistat In Pakistan is a medicine which can help you to lose weight if you are overweight or obese. Orlistat works by blocking chemicals (enzymes) in your gut that digest fat. Nearly a third of the fat that you eat is blocked by orlistat. The undigested fat is not absorbed into your body and is passed out with your stools (feces). The normal dose is one capsule – 120 mg, three times a day with each meal. However, you do not need to take one if there is no fat in the meal or if you miss a meal.
Liraglutide is a new medicine that was licensed for the treatment of obesity in January 2017. There has been the limited experience with this treatment, which is only available in injectable form. It is currently mainly being used in specialist centers for people whose obesity has led them to develop other illnesses such as diabetes.
Two other medicines – sibutramine and rimonabant – previously used to help with weight loss are no longer available in the UK because of concerns about their safety.
This medication is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight. It is used by certain overweight people, such as those who are obese or have weight-related medical problems. Taking orlistat can also help keep you from gaining back the weight you have lost. Losing weight and keeping it off can lessen the many health risks that come with obesity, including heart disease, diabetes, high blood pressure, and a shorter life. Dietary fats need to be broken down into smaller pieces before the body can absorb them. Orlistat works by blocking the enzyme that breaks down fats in your diet. This undigested fat then passes out of your body in your bowel movement. Orlistat does not block the absorption of calories from sugar and other non-fat foods, so you still need to restrict your total intake of calories.
Reviews
There are no reviews yet.